Viewing Study NCT06105632


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2025-12-25 @ 7:24 PM
Study NCT ID: NCT06105632
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-16
First Post: 2023-10-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module